VVOS
Vivos Therapeutics, Inc.
Key Financials
Gross Profit
$10.5M
↑ 16.9%
Revenue
$17.4M
↑ 16.0%
Net Income
$-21170000
↓ 90.1%
Operating Income
$-19894000
↓ 78.1%
Total Assets
$25.2M
↑ 64.6%
Total Liabilities
$26.7M
↑ 264.3%
Shareholders' Equity
$-1490000.00
↓ 118.7%
EPS (Diluted)
$-2.07
↑ 6.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/14/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 8-K | 8/11/2026 | View on SEC |
| SCHEDULE 13G | 8/11/2026 | View on SEC |
| 8-K | 8/3/2026 | View on SEC |
| SCHEDULE 13D | 7/15/2026 | View on SEC |
| 4 | 7/15/2026 | View on SEC |
| 3 | 7/15/2026 | View on SEC |
| 8-K | 7/7/2026 | View on SEC |
| 8-K | 6/25/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | VVOS |
| Company Name | Vivos Therapeutics, Inc. |
| CIK | 1716166 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (866)908-4867 |